In summary, AZD8931 resulted in tumour shrinkage in the majority of MMTV-NIC PTEN+/+ animals, but although it slowed tumour growth in MMTV-NIC PTEN+/− animals it did not cause tumour resolution. Here, PTEN is linked to neoplasm.